` SELEC.E (Selcuk Ecza Deposu Ticaret ve Sanayi AS) vs BIST 100 Comparison - Alpha Spread

SELEC.E
vs
BIST 100

Over the past 12 months, SELEC.E has outperformed BIST 100, delivering a return of 35% compared to the BIST 100's 27% growth.

Stocks Performance
SELEC.E vs BIST 100

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SELEC.E vs BIST 100

Loading
SELEC.E
BIST 100
Difference

Performance By Year
SELEC.E vs BIST 100

Loading
SELEC.E
BIST 100
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Selcuk Ecza Deposu Ticaret ve Sanayi AS vs Peers

BIST 100
SELEC.E
MCK
COR
0HF3
CAH
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Selcuk Ecza Deposu Ticaret ve Sanayi AS
Glance View

Market Cap
50.6B TRY
Industry
Health Care

In the dynamic landscape of Turkey's pharmaceutical industry, Selçuk Ecza Deposu Ticaret ve Sanayi A.Ş. stands as a formidable force, deftly operating as a bridge between pharmaceutical manufacturers and healthcare providers. Established in 1958, the company has cultivated an extensive distribution network that covers the length and breadth of Turkey. With a meticulously coordinated logistics framework, Selçuk Ecza ensures that a vast array of pharmaceutical products—from essential medicines to specialized healthcare solutions—reach pharmacies, hospitals, and healthcare institutions efficiently. This seamless operation is buoyed by the company’s ability to adapt to the ever-changing regulatory environment and consumer demands, thereby ensuring its relevance in the market for decades. The essence of Selçuk Ecza’s business model lies in its comprehensive approach to distribution, where it capitalizes on economies of scale to ensure cost-effectiveness while maintaining high-quality service standards. Revenue is generated primarily through the sales margins on the wide range of pharmaceuticals it distributes. The company’s proficiency in maintaining robust relationships with global pharmaceutical giants and local suppliers alike underpins its substantial market share. Furthermore, by embracing technological advancements, such as real-time inventory management systems, Selçuk Ecza optimizes its supply chain operations, minimizing delays and maximizing efficiency. This strategic prowess not only cements its position as a leading distributor in Turkey but also fosters sustainable growth by continuously aligning with the dynamic healthcare industry.

SELEC.E Intrinsic Value
106.97 TRY
Undervaluation 24%
Intrinsic Value
Price
Back to Top